<a id="article1.body1.sec3.sec2.p5" name="article1.body1.sec3.sec2.p5"></a><p>During 2002, before the start of the ART programme, there were 153 deaths among army personnel. In 2006, while staff numbers had remained similar, annual deaths had dropped to 36 (<a href="#pone-0001445-g001"><strong>Figure 1</strong></a><strong>)</strong>. This represents a dramatic 76% reduction in all-cause mortality between 2002 and 2006.</p>

</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>We believe that this is the first national survey in Sub-Saharan Africa of army personnel on ART examining uptake, retention on therapy and the impact that this has had over the last 5 years in reducing death rates. By the end of 2006, a total of 547 army personnel had been started on ART, the majority from the 4 army clinics that provide ART in Malawi. These army clinics operate on average the same number of clinic days per week and have the same ART clinic staffing complement as the other clinics around the country, and no clinic has experienced an ART drug stock out since national scale up started in 2004.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>Army personnel differed from the general population accessing ART from public sector sites on several counts: there were more males; more patients started on ART due to being in stage 1 and 2 with a low CD4 count and due to being in WHO clinical stage 4; there was a low default rate and a higher transfer-out rate; and survival probabilities, at least up to 12–18 months were higher than for the general population. The findings in fact are more similar to those seen in the private sector in Malawi, and are not surprising. The majority of army personnel in Malawi are male. Because the main army clinics are situated in cities, there is relatively good access to laboratories that can perform CD4-lymphocyte tests and this may be one of the main reasons why a higher proportion of army personnel start ART due to being in WHO clinical stage 1 and 2. Why more army personnel start ART due to being in WHO clinical stage 4 is not known, but this may reflect a more comprehensive clinical assessment of patients. The Defence Force can maintain good follow-up of its patients, hence the low default rate. There was a high transfer rate due to frequent postings to different parts of the country. Recent operation research in Malawi (Yu, unpublished observations) shows that the majority of patients who transfer-out do in fact transfer-in at another site, and most of these patients subsequently stay alive and on therapy. Survival probabilities are good, probably due to larger numbers of the Defence Force accessing ART at an earlier stage of HIV disease and possibly due to the higher measured drug adherence in patients attending army clinics compared with that seen in the general population.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>Without ART, HIV-infected patients assessed in WHO clinical stage 3 or 4 have a very poor prognosis in Malawi <a href="#pone.0001445-vanOosterhout1">[6]</a>, while on ART the prognosis is transformed. Without the national ART program, it is likely that annual death rates in the army would have continued to increase over the last 5 years. With the ever increasing number of army personnel retained alive on treatment, this trend has been impressively reversed. This is corroborated by the 76% reduction in all-cause mortality between 2002 and 2006, which was observed independently in army staff records. It is likely that other occupational groups have benefited from a similar impact <a href="#pone.0001445-Makombe1">[7]</a>.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>This operational study was based on data from the routine national monitoring system, and therefore has some limitations. Occupation was unknown for about 3% of patients, and this may have lead to a small undercounting of the number of army personnel who accessed ART in the country. It is also possible that some patients felt uncomfortable registering as a member of the Malawi Defence Force in ART clinics outside of the army health services, and may have given a different occupation to ART clinic staff. The average observation time of the national cohort of army personnel is still relatively short, and longer term outcomes could not be reliably assessed. The strengths of the study are that this is a full national survey, all ART-providing facilities in the public and private sector of Malawi were included, and the analysis is likely to provide near-complete information on all army personnel who have accessed treatment in the country, provided that they have been accurately recorded in the occupation column of the register. Malawi has established a standard, national monitoring system for ART used by all public and private sector facilities, the data are routinely validated during quarterly supervision through cross-checking of master cards and ART registers, ensuring high data quality. Occupation was available for 97% of patients and assuming that recording was accurate, the survey is likely to provide near-complete information on all army personnel started on ART in Malawi.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>The Malawi Defence Force has shown outstanding leadership in its management of HIV/AIDS. First, it provided at its own expense ART for its personnel before the national scale up commenced. Second, it was pro-active in its desire to be part of the national ART scale up, with army medical personnel participating in the development and implementation of national plans and the national training curriculum. The four army clinics provide therapy to the majority of army personnel, and through a disciplined approach to follow-up the army has achieved excellent treatment outcomes. This approach should serve as an example to other defence forces in the world, as well as large companies in both the private and public sector.</p>
</div>



<div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: AH SM ES KK AB AJ. Performed the experiments: AH SM SC JK ES AB AJ BH RW AN. Analyzed the data: AH SM HT AB AJ. Contributed reagents/materials/analysis tools: AH SM AB AJ. Wrote the paper: AH SM HT SC JK ES KK AB AJ BH RW AN.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001445-Harries1" id="pone.0001445-Harries1"></a>Harries AD, Libamba E, Schouten EJ (2006) Scaling up antiretroviral treatment in resource-poor settings. Lancet  367: 1870–1872.  <ul class="find" data-citedArticleID="1042536" data-doi="10.1016/s0140-6736(06)68809-0"><li><a href="http://dx.doi.org/10.1016/s0140-6736(06)68809-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Scaling+up+antiretroviral+treatment+in+resource-poor+settings." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Scaling+up+antiretroviral+treatment+in+resource-poor+settings.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001445-Libamba1" id="pone.0001445-Libamba1"></a>Libamba E, Makombe S, Harries AD, Chimzizi R, Salaniponi FM, et al.  (2005) Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes–the case of Malawi. Int J Tuberc Lung Dis  9: 1062–1071.  <ul class="find" data-citedArticleID="1042538"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Scaling+up+antiretroviral+therapy+in+Africa%3A+learning+from+tuberculosis+control+programmes%3Fthe+case+of+Malawi.&amp;auth=&amp;atitle=Scaling+up+antiretroviral+therapy+in+Africa%3A+learning+from+tuberculosis+control+programmes%3Fthe+case+of+Malawi." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Scaling+up+antiretroviral+therapy+in+Africa%3A+learning+from+tuberculosis+control+programmes%E2%80%93the+case+of+Malawi." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Scaling+up+antiretroviral+therapy+in+Africa%3A+learning+from+tuberculosis+control+programmes%E2%80%93the+case+of+Malawi.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001445-Libamba2" id="pone.0001445-Libamba2"></a>Libamba E, Makombe S, Mhango E, de Ascurra Teck O, Limbambala E, et al.  (2006) Supervision, monitoring and evaluation of nationwide scale up of antiretroviral therapy in Malawi. Bulletin World Health Organization  84: 320–326.  <ul class="find" data-citedArticleID="1042540"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Supervision%2C+monitoring+and+evaluation+of+nationwide+scale+up+of+antiretroviral+therapy+in+Malawi.&amp;auth=&amp;atitle=Supervision%2C+monitoring+and+evaluation+of+nationwide+scale+up+of+antiretroviral+therapy+in+Malawi." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Supervision%2C+monitoring+and+evaluation+of+nationwide+scale+up+of+antiretroviral+therapy+in+Malawi." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Supervision%2C+monitoring+and+evaluation+of+nationwide+scale+up+of+antiretroviral+therapy+in+Malawi.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001445-World1" id="pone.0001445-World1"></a>World Health Organization (2006) Antiretroviral therapy of HIV infection in adults and adolescents in resource-limited settings, towards universal access: recommendations for a public health approach. Geneva: World Health Organization.   <ul class="find-nolinks"></ul></li><li><span class="label">5.
              </span><a name="pone.0001445-Ministry1" id="pone.0001445-Ministry1"></a>Ministry of Health, Malawi (2006) Treatment of AIDS. Guidelines for the use of antiretroviral therapy in Malawi. Second edition, April 2006. Lilongwe, Malawi.  <ul class="find-nolinks"></ul></li><li><span class="label">6.
              </span><a name="pone.0001445-vanOosterhout1" id="pone.0001445-vanOosterhout1"></a>van Oosterhout JG, Laufer MK, Graham SM, Thumba F, Perez A, et al.  (2005) A community-based study on the incidence of trimethoprim-sulfamethoxazole-preventabl​einfections in Malawian adults living with HIV. J Acquir Immune Defic Syndr  39: 626–631.  <ul class="find" data-citedArticleID="1042548"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=A+community-based+study+on+the+incidence+of+trimethoprim-sulfamethoxazole-preventable+infections+in+Malawian+adults+living+with+HIV.&amp;auth=&amp;atitle=A+community-based+study+on+the+incidence+of+trimethoprim-sulfamethoxazole-preventable+infections+in+Malawian+adults+living+with+HIV." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+community-based+study+on+the+incidence+of+trimethoprim-sulfamethoxazole-preventable+infections+in+Malawian+adults+living+with+HIV." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+community-based+study+on+the+incidence+of+trimethoprim-sulfamethoxazole-preventable+infections+in+Malawian+adults+living+with+HIV.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001445-Makombe1" id="pone.0001445-Makombe1"></a>Makombe SD, Jahn A, Tweya H, Chuka S, Yu JK-L, et al.  (2007) A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival. PLoS ONE  2 (7): e620: 1–5.  <ul class="find" data-citedArticleID="1042542" data-doi="10.1371/journal.pone.0000620"><li><a href="http://dx.doi.org/10.1371/journal.pone.0000620" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+national+survey+of+teachers+on+antiretroviral+therapy+in+Malawi%3A+access%2C+retention+in+therapy+and+survival." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+national+survey+of+teachers+on+antiretroviral+therapy+in+Malawi%3A+access%2C+retention+in+therapy+and+survival.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.XML" value="39975"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.PDF" value="107950"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t001.PNG_L" value="75104"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t001.PNG_M" value="101181"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t001.PNG_S" value="14526"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t001.TIF" value="308258"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t001.PNG_I" value="34627"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t002.PNG_L" value="120312"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t002.PNG_M" value="159220"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t002.PNG_S" value="20035"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t002.TIF" value="498382"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.t002.PNG_I" value="53988"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.g001.PNG_L" value="159611"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.g001.PNG_M" value="35100"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.g001.PNG_S" value="6467"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.g001.TIF" value="312872"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001445.g001.PNG_I" value="11897"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001445&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001445" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001445&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001445&volume=&issue=&title=Antiretroviral Therapy in the Malawi Defence Force: Access, Treatment Outcomes and Impact on Mortality&author_name=Alfred%20C.%20Banda%2C%20Simon%20D.%20Makombe%2C%20Andreas%20Jahn%2C%20Hannock%20Tweya%2C%20Stuart%20Chuka%2C%20Joseph%20Kwong-Leung%20Yu%2C%20Bethany%20Hedt%2C%20Ralf%20Weigel%2C%20Amon%20Nkhata%2C%20Erik%20J.%20Schouten%2C%20Kelita%20Kamoto%2C%20Anthony%20D.%20Harries&start_page=1&end_page=4" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001445" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001445" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001445" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001445&amp;t=Antiretroviral%20Therapy%20in%20the%20Malawi%20Defence%20Force%3A%20Access%2C%20Treatment%20Outcomes%20and%20Impact%20on%20Mortality" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001445&title=Antiretroviral%20Therapy%20in%20the%20Malawi%20Defence%20Force%3A%20Access%2C%20Treatment%20Outcomes%20and%20Impact%20on%20Mortality&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001445&amp;title=Antiretroviral%20Therapy%20in%20the%20Malawi%20Defence%20Force%3A%20Access%2C%20Treatment%20Outcomes%20and%20Impact%20on%20Mortality" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001445" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001445&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Antiretroviral Therapy in the Malawi Defence Force: Access, Treatment Outcomes and Impact on Mortality';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001445';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Antiretroviral%20Therapy%20in%20the%20Malawi%20Defence%20Force%3A%20Access%2C%20Treatment%20Outcomes%20and%20Impact%20on%20Mortality http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001445" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001445" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">



















          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antiretroviral+therapy%22" title="Search for articles in the subject area:'Antiretroviral therapy'"><div class="flagText">Antiretroviral therapy</div></a>
              <div data-categoryid="32515" data-articleid="25718"
                   data-categoryname="Antiretroviral therapy"
                   class="flagImage" title="Flag 'Antiretroviral therapy' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Death+rates%22" title="Search for articles in the subject area:'Death rates'"><div class="flagText">Death rates</div></a>
              <div data-categoryid="51935" data-articleid="25718"
                   data-categoryname="Death rates"
                   class="flagImage" title="Flag 'Death rates' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Drug+adherence%22" title="Search for articles in the subject area:'Drug adherence'"><div class="flagText">Drug adherence</div></a>
              <div data-categoryid="25983" data-articleid="25718"
                   data-categoryname="Drug adherence"
                   class="flagImage" title="Flag 'Drug adherence' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22HIV%22" title="Search for articles in the subject area:'HIV'"><div class="flagText">HIV</div></a>
              <div data-categoryid="42663" data-articleid="25718"
                   data-categoryname="HIV"
                   class="flagImage" title="Flag 'HIV' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Malawi%22" title="Search for articles in the subject area:'Malawi'"><div class="flagText">Malawi</div></a>
              <div data-categoryid="40965" data-articleid="25718"
                   data-categoryname="Malawi"
                   class="flagImage" title="Flag 'Malawi' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Military+personnel%22" title="Search for articles in the subject area:'Military personnel'"><div class="flagText">Military personnel</div></a>
              <div data-categoryid="27655" data-articleid="25718"
                   data-categoryname="Military personnel"
                   class="flagImage" title="Flag 'Military personnel' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Nurses%22" title="Search for articles in the subject area:'Nurses'"><div class="flagText">Nurses</div></a>
              <div data-categoryid="18791" data-articleid="25718"
                   data-categoryname="Nurses"
                   class="flagImage" title="Flag 'Nurses' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Professions%22" title="Search for articles in the subject area:'Professions'"><div class="flagText">Professions</div></a>
              <div data-categoryid="46127" data-articleid="25718"
                   data-categoryname="Professions"
                   class="flagImage" title="Flag 'Professions' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=6486'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=167'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=1376&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=41935"></a><br>Posted by sijmenschoustra</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
